Literature DB >> 7376825

Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy.

D R Crapper, S Quittkat, S S Krishnan, A J Dalton, U De Boni.   

Abstract

Nuclear and chromatin fractions were prepared from cerebral cortex of 34 human and 37 animal brains. Chromatin was separated into a heavy heterochromatin fraction and two euchromatin fractions: intermediate euchromatin and light euchromatin. Compared to age-matched controls, aluminum content expressed per gram of DNA was significantly increased in nuclear and heterochromatin fractions in pre-senile Alzheimer's disease. In contrast nuclear preparations from brains of patients who had died with dialysis encephalopathy contained less aluminum than controls, although whole tissue concentrations were elevated ten to fifteen times above the control concentrations. Direct injection of aluminum into the cerebrospinal fluid of cats resulted in a progressive encephalopathy with neurofibrillary degeneration and increased intranuclear aluminum content. It is speculated that in Alzheimer's disease the normal blood-brain and cytoplasmic barriers for this neurotoxic metal are defective permitting aluminum to gain access to DNA-containing constitutents of the nuclei.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7376825     DOI: 10.1007/bf00688530

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  25 in total

1.  EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION. I. LIGHT MICROSCOPIC OBSERVATIONS.

Authors:  I KLATZO; H WISNIEWSKI; E STREICHER
Journal:  J Neuropathol Exp Neurol       Date:  1965-04       Impact factor: 3.685

2.  ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA.

Authors:  R D TERRY; N K GONATAS; M WEISS
Journal:  Am J Pathol       Date:  1964-02       Impact factor: 4.307

3.  Interactions of mercury and copper with constitutive heterochromatin and euchromatin in vivo and in vitro.

Authors:  S E Bryan; S J Simons; D L Vizard; K J Hardy
Journal:  Biochemistry       Date:  1976-04-20       Impact factor: 3.162

4.  Composition of deoxyribonucleoprotein in human brain.

Authors:  N Robinson
Journal:  Clin Chim Acta       Date:  1966-10       Impact factor: 3.786

5.  Effect of cations on the consideration of hen erythrocyte nuclei and its relation to gene activation.

Authors:  R E Leake; M E Trench; J M Barry
Journal:  Exp Cell Res       Date:  1972-03       Impact factor: 3.905

6.  Aluminium and Alzheimer's disease.

Authors:  J R McDermott; A I Smith; K Iqbal; H M Wisniewski
Journal:  Lancet       Date:  1977-10-01       Impact factor: 79.321

7.  Effect of aluminum upon conditioned avoidance response acquisition in the absence of neurofibrillary degeneration.

Authors:  G A King; U De Boni; D R Crapper
Journal:  Pharmacol Biochem Behav       Date:  1975 Nov-Dec       Impact factor: 3.533

8.  Altered chromatin conformation in Alzheimer's disease.

Authors:  D R Crapper; S Quittkat; U de Boni
Journal:  Brain       Date:  1979-09       Impact factor: 13.501

9.  Aluminum levels in brain in Alzheimer's disease.

Authors:  G A Trapp; G D Miner; R L Zimmerman; A R Mastri; L L Heston
Journal:  Biol Psychiatry       Date:  1978-12       Impact factor: 13.382

10.  Dementia, renal failure, and brain aluminum.

Authors:  A I Arieff; J D Cooper; D Armstrong; V C Lazarowitz
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

View more
  34 in total

1.  Aluminium may cause senile dementia and bone fragility.

Authors:  B Mjöberg
Journal:  Calcif Tissue Int       Date:  1990-11       Impact factor: 4.333

Review 2.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

3.  Aluminum neurotoxicity in mammals.

Authors:  H M Wisniewski; R C Moretz; J A Sturman; G Y Wen; J W Shek
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

4.  Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease.

Authors:  D R Crapper McLachlan; W J Lukiw; T P Kruck
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

5.  First evidence on induced topological changes in supercoiled DNA by an aluminium D-aspartate complex.

Authors:  Kosagi S Jagannatha Rao; Reuven Stein
Journal:  J Biol Inorg Chem       Date:  2003-09-27       Impact factor: 3.358

Review 6.  [Aluminum toxicity].

Authors:  H V Henning
Journal:  Klin Wochenschr       Date:  1989-12-15

7.  Actions of aluminum on voltage-activated calcium channel currents.

Authors:  B Platt; D Büsselberg
Journal:  Cell Mol Neurobiol       Date:  1994-12       Impact factor: 5.046

8.  The effects of Al on the calcium currents in Helix neurons.

Authors:  I Farkas; L Erdélyi
Journal:  Cell Mol Neurobiol       Date:  1994-12       Impact factor: 5.046

9.  Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease.

Authors:  W J Lukiw; H J LeBlanc; L A Carver; D R McLachlan; N G Bazan
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

10.  Inhibition of corticosterone binding in vitro, in rabbit hippocampus, by chromatin bound aluminum.

Authors:  C Sanderson; D R McLachlan; U De Boni
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.